Accurately assessing cancer risk in average- and high-risk individuals is an important
component to controlling the suffering and death due to cancer. Cancer risk prediction
models provide an important approach to assessing risk and susceptibility by:
identifying individuals at high risk;
facilitating the design and planning of clinical chemoprevention trials;
enabling the development of benefit-risk indices;
allowing the evaluation of interventions; and
providing estimates of the population burden and cost of cancer.
This National Cancer Institute (NCI) Web site aims to provide resources to clinicians
and researchers who are developing new and improving existing models for cancer risk,
validating these models and evaluating their utility in research and clinic settings.